UCRF News
News and stories about UCRF accomplishments
-
UNC researchers develop faster, low-cost method to diagnose common pediatric cancer
Jeremy R. Wang, PhD, and colleagues have created a new way for oncologists to more sensitively detect genetic mutations in B-cell acute lymphoblastic leukemia (B-ALL), the most common type of pediatric cancer.
-
Investigating approaches to make lung cancer screening more effective
To better understand the burdens of false-positive lung cancer screenings and ways to mitigate them, the NCI awarded UNC Lineberger researchers a $3.2 million grant to identify the potential harms of false-positive results at the patient, clinician, and facility levels.
-
“Data for everyone”: A new cancer dashboard launches at UNC Lineberger Comprehensive Cancer Center
UNC Lineberger has launched a resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs throughout the state.
-
Community Advisory Board engages NC communities in the fight against cancer
UNC Lineberger’s Community Advisory Board works to make sure cancer research reflects community needs across the state, and to raise public awareness of cancer’s signs and symptoms.
-
Building tools to help doctors better track patient symptoms, improve outcomes
Digital reporting technologies created by UNC Lineberger researchers are now being used in North Carolina and across the country to improve care and outcomes for cancer patients.
-
UNC Lineberger continues its national leadership in breast cancer research
UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.
-
‘If you’re trying to make a difference in cancer, you can’t go slow’
Chad Pecot, MD, leads cancer RNA research at UNC Lineberger, creating innovative therapies and promising treatment strategies for multiple cancer mutations.
-
Uniquely engineered KRAS-targeted cancer drug found to be effective in early studies
Chad Pecot, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KRAS G12V could potentially stop KRAS-dependent cancers in their tracks.